Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
ALIMERA SCIENCES INC | Chief Financial Officer & SVP | Common Stock | 75.5K | $292K | $3.86 | Nov 21, 2023 | Direct |
Processa Pharmaceuticals, Inc. | Chief Financial Officer | Restricted Stock Units | 28K | $68.7K | $2.45 | Jul 16, 2024 | Direct |
ROCKWELL MEDICAL, INC. | EVP, Chief Financial Officer and Chief Business Officer | Stock Option (Right to Buy) | 80K | Sep 9, 2022 | Direct | ||
ALIMERA SCIENCES INC | Chief Financial Officer & SVP | Employee Stock Option (Right to Buy) | 50K | Nov 21, 2023 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
PCSA | Processa Pharmaceuticals, Inc. | Jul 16, 2024 | 1 | $0 | 4 | Jul 18, 2024 | Chief Financial Officer |
PCSA | Processa Pharmaceuticals, Inc. | Jul 16, 2024 | 0 | $0 | 3 | Jul 18, 2024 | Chief Financial Officer |
ALIM | ALIMERA SCIENCES INC | Nov 21, 2023 | 1 | $0 | 4 | Nov 28, 2023 | Chief Financial Officer & SVP |
ALIM | ALIMERA SCIENCES INC | Mar 26, 2023 | 1 | $0 | 4 | Mar 28, 2023 | Chief Financial Officer & SVP |
ALIM | ALIMERA SCIENCES INC | Jan 9, 2023 | 2 | $0 | 4 | Jan 10, 2023 | Chief Financial Officer & SVP |
ALIM | ALIMERA SCIENCES INC | Jan 9, 2023 | 0 | $0 | 3 | Jan 10, 2023 | Chief Financial Officer & SVP |
RMTI | ROCKWELL MEDICAL, INC. | Sep 9, 2022 | 1 | $0 | 4 | Sep 13, 2022 | EVP, Chief Financial Officer and Chief Business Officer |